Skip to main content

Table 5 Univariate analysis of prognostic factors for survival in patients with PB-DLBCL

From: Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas

Parameter

PFS

OS

3-year

5-year

P

3-year

5-year

P

Overall, %

60.8

45.9

Ā 

78.8

68.0

Ā 

Age

Ā Ā 

0.278

Ā Ā 

0.004

<60Ā years, %

64.5

46.9

Ā 

87.9

80.6

Ā 

ā‰„60Ā years, %

50.3

40.2

Ā 

57.9

44.3

Ā 

Sex

Ā Ā 

0.634

Ā Ā 

0.410

Male, n (%)

63.9

52.1

Ā 

80.2

71.0

Ā 

Female, n (%)

53.4

44.8

Ā 

71.9

61.4

Ā 

B symptoms

Ā Ā 

0.673

Ā Ā 

0.289

No, %

62.5

52.4

Ā 

80.5

74.3

Ā 

Yes, %

50.0

31.5

Ā 

66.1

45.8

Ā 

LDH

Ā Ā 

0.011

Ā Ā 

0.018

Normal, %

73.6

58.2

Ā 

89.2

68.2

Ā 

Elevated, %

34.8

21.9

Ā 

55.2

38.2

Ā 

Lymph node involvement

Ā Ā 

0.143

Ā Ā 

0.231

No, %

66.8

60.0

Ā 

81.4

75.1

Ā 

Yes, %

15.6

2.2

Ā 

64.0

44.3

Ā 

Bone marrow involvement

Ā Ā 

0.719

Ā Ā 

0.319

No, %

59.1

42.0

Ā 

80.0

72.3

Ā 

Yes, %

72.9

72.9

Ā 

54.9

42.0

Ā 

Sites

Ā Ā 

0.022

Ā Ā 

0.022

Appendicular, %

66.7

51.1

Ā 

78.4

70.6

Ā 

Axial, %

59.1

59.1

Ā 

100.0

100.0

Ā 

Both, %

5.6

0

Ā 

61.4

61.4

Ā 

Number of bone sites

Ā Ā 

0.001

Ā Ā 

<0.001

Unifocal, %

75.7

75.7

Ā 

89.2

83.5

Ā 

Multifocal, %

36.8

13.4

Ā 

53.1

36.7

Ā 

Stage

Ā Ā 

0.005

Ā Ā 

0.001

IE/IIE, %

73.8

73.8

Ā 

97.1

97.1

Ā 

IVE, %

43.0

18.0

Ā 

58.5

49.8

Ā 

CD10

Ā Ā 

0.267

Ā Ā 

0.077

Negative, %

52.9

29.8

Ā 

76.8

65.2

Ā 

Positive, %

64.4

55.2

Ā 

95.7

95.7

Ā 
  1. Bold values indicate statistical significance (P<0.05).